Industry / China
Novo Nordisk Donates Chemical Library To Chinese Research Institute
May 2008 | Company News AlertThe pharmaceutical industry is frequently accused as being motivated by profits over patients. Terms like patent evergreening and disease mongering are an ongoing smear on a sector that truly does seek to reduce the burden of disease through the commercial application of science. Therefore, it is with pleasure that BMI can highlight an altruistic development that goes some way to improving the image of
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
